BCR and lymphoma: Furthermore, inhibition of BCR pathways also interferes with BCR-regulated interactions with the TME, which leads to disruption of secretion of pro-survival chemokines, increased release of lymphoma cells from the lymph nodes, and enhanced tumor cell death [147,148].